Skip to main content
Fig. 6 | Cancer Cell International

Fig. 6

From: Prediction of hepatocellular carcinoma prognosis and immunotherapeutic effects based on tryptophan metabolism-related genes

Fig. 6

Clinical application of risk models for predicting prognosis and response to immunotherapeutic effect. A Univariate Cox analysis of clinical characteristics and RiskType based on TCGA database. B Multivariate Cox analysis of clinical characteristics and RiskType. C In the IMvigor210 cohort, SD/PD patients had higher risk scores than other types of responders. D The percentage statistics showed that the treatment effect was significantly better in the low-risk group than in the high-risk group. E Prognostic difference in risk subgroups in the whole TCGA-LIHC cohort. Prognostic difference in early-stage patients in the IMvigor210 cohort. Prognostic difference between different risk groups of early-stage patients (F) and late-stage patients in the IMvigor210 cohort (G)

Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us